Alcoholism: Difference between revisions
imported>Pierre-Alain Gouanvic m (→See also) |
imported>Robert Badgett (Started 'Diagnosis') |
||
| Line 18: | Line 18: | ||
===Post-recovery=== | ===Post-recovery=== | ||
==Diagnosis== | |||
A [[systematic review]] concluded "full AUDIT may be superior to the AUDIT-C."<ref name="pmid19075207">{{cite journal |author=Kriston L, Hölzel L, Weiser AK, Berner MM, Härter M |title=Meta-analysis: are 3 questions enough to detect unhealthy alcohol use? |journal=Ann. Intern. Med. |volume=149 |issue=12 |pages=879–88 |year=2008 |month=December |pmid=19075207 |doi= |url=http://www.annals.org/cgi/pmidlookup?view=long&pmid=19075207 |issn=}}</ref> | |||
==Treatment== | ==Treatment== | ||
Revision as of 07:58, 7 January 2009
Images of a 61-year-old healthy man (upper images) and a 60-year-old alcoholic man (lower images). Note on the MRI the thinner corpus callosum displaced upward by enlarged ventricles and, on the DTI, less well delineated white matter tracts in the alcoholic man compared with the healthy man.
Alcoholism is a chronic condition, the development and presentation of which is influenced by genetic, psychosocial, and environmental factors. As a disease process, it is often progressive, and sometimes fatal. Alcholism is typically characterized by impaired impulse control, preoccupation with alcohol, continued use of alcohol despite adverse consequences, and a generalized distortion in thinking. While the condition itself is considered chronic, the symptom profile may present either continuously or periodically." [1]
Alcoholic styles
Chronic drinking
Maintenance drinking
Binge drinking
Blackout drinking
Recovery styles
The 'dry drunk'
In recovery
Post-recovery
Diagnosis
A systematic review concluded "full AUDIT may be superior to the AUDIT-C."[2]
Treatment
Medications
Baclofen
Baclofen is a a selective GABA B-receptor agonist that in a single trial of patients with alcoholic cirrhosis improved abstinence rates (71% versus 29%) over three months.[3]
Disulfiram
A randomized controlled trial showed benefit from disulfiram [4]
Topiramate
A randomized controlled trial of volunteers showed benefit from topiramate.[3]
Naltrexone
Randomized controlled trials show conflicting benefit from naltrexone with benefit among recent abstainers[5] and no benefit from chronic users[6].
See also
References
- ↑ National Library of Medicine. Alcoholism. Retrieved on 2007-12-06.
- ↑ Kriston L, Hölzel L, Weiser AK, Berner MM, Härter M (December 2008). "Meta-analysis: are 3 questions enough to detect unhealthy alcohol use?". Ann. Intern. Med. 149 (12): 879–88. PMID 19075207. [e]
- ↑ 3.0 3.1 2007. Lancet Cite error: Invalid
<ref>tag; name "pmidpending" defined multiple times with different content - ↑ Fuller RK, Branchey L, Brightwell DR, et al (1986). "Disulfiram treatment of alcoholism. A Veterans Administration cooperative study". JAMA 256 (11): 1449–55. PMID 3528541. [e]
- ↑ Anton RF, O'Malley SS, Ciraulo DA, et al (2006). "Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial". JAMA 295 (17): 2003–17. DOI:10.1001/jama.295.17.2003. PMID 16670409. Research Blogging.
- ↑ Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001). "Naltrexone in the treatment of alcohol dependence". N. Engl. J. Med. 345 (24): 1734–9. DOI:10.1056/NEJMoa011127. PMID 11742047. Research Blogging.